A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Eurostar passengers were left stranded last night after migrants reportedly climbed on top of trains at Calais.
Andy Burnham is set to criticise those who question membership of international alliances and institutions in favour of 'isolationism'.
Wrestling legend Jimmy Snuka has been charged over the death of his girlfriend more than 30 years ago.